Drug Discovery

22 Oct 2020
- Drug Discovery
- Research & Development
EffRx Pharmaceuticals signs exclusive license agreement with Diurnal for registration and commercialisation of Alkindi

By PBR Staff Writer

EffRx Pharmaceuticals SA, a commercial-stage company that commercializes niche and orphan medicines in Switzerland and Europe, announced it has recently entered into an exclusive license agreement with Diurnal Group plc, a specialty pharmaceutical company targeting patient needs in chronic endocrine diseases, for the registration and commercialization of Alkindi for pediatric adrenocortical insufficiency (AI) in Switzerland.
19 Oct 2020
Drug Discovery
Research & Development
Dren Bio announces a $60M Series A financing

By PBR Staff Writer

Dren Bio, Inc., a company developing powerful protein-engineering technologies for depletion of cells, protein aggregates and other disease-causing agents, announced the closing of a $60 million Series A investment round.
16 Oct 2020
Drug Discovery
Pre-clinical Studies
Sanofi, Translate Bio mRNA Covid-19 vaccine candidate induced high antibody levels in preclinical studies

By PBR Staff Writer

Sanofi Pasteur, the vaccines global business unit of Sanofi, and Translate Bio (NASDAQ: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company, today announced the preclinical results for MRT5500, a mRNA-based vaccine candidate against SARS-CoV-2, the virus that causes COVID-19 disease.
16 Oct 2020
Drug Discovery
Research & Development
Eli Lilly to buy biotechnology firm Disarm Therapeutics

By PBR Staff Writer

Eli Lilly and Company has agreed to acquire privately-held biotechnology company Disarm Therapeutics for an upfront payment of $135m.
13 Oct 2020
Drug Discovery
Research & Development
HitGen to acquire fragment and structure-based biotech company Vernalis

By PBR Staff Writer

HitGen announces it has entered into a definitive agreement with Ligand Pharmaceuticals to acquire Vernalis (R&D) Limited, Cambridge, UK-based world leaders in fragment and structure-based drug discovery research.
07 Oct 2020
Drug Discovery
Research & Development
Scribe Therapeutics, Biogen collaborate to develop CRISPR-based genetic medicines

By PBR Staff Writer

Molecular engineering company Scribe Therapeutics has entered into a research collaboration with Biogen for the development of CRISPR-based genetic medicines for neurological diseases.
06 Oct 2020
Drug Discovery
Research & Development
Bristol Myers Squibb to buy biopharmaceutical firm MyoKardia for $13.1bn

By PBR Staff Writer

Bristol Myers Squibb (BMS) has signed an agreement to acquire clinical-stage biopharmaceutical company MyoKardia for $13.1bn.
02 Oct 2020
Drug Discovery
Research & Development
Covis Group to buy AMAG Pharmaceuticals for $498m

By PBR Staff Writer

Covis Group has agreed to acquire US-based commercial-stage biopharmaceutical company AMAG Pharmaceuticals for about $498m on a fully diluted basis.
01 Oct 2020
Drug Discovery
Research & Development
Pfizer to acquire minority stake in CStone Pharmaceuticals for $200m

By PBR Staff Writer

Pfizer has announced an equity investment of $200m to purchase a 9.90% stake in biopharmaceutical company CStone Pharmaceuticals.
30 Sep 2020
Drug Discovery
Research & Development
Orgenesis to acquire regenerative medicine company Koligo Therapeutics

By PBR Staff Writer

Biotechnology company Orgenesis has signed an agreement to acquire US-based regenerative medicine company Koligo Therapeutics.

Drug Discovery

Research & Development

Construction begins on Novartis’ RLT centre in Texas, US

Angelini Pharma to acquire Catalyst Pharmaceuticals for equity value of $4.1bn

Clinical Trials

Patient Enrollment

US FDA approves Avacta Group’s IND application for AVA6000

AM-Pharma enrols first patients in Covid-19 phase III trial

Regulation

Drug Filing

Viatris files applications in Japan for approval of Effexor to treat GAD

Scholar Rock submits application of SMA therapy to FDA

Production & Sales

Manufacturing

ENCell and Lucy Biotech forge alliance for mesenchymal stem cell therapy

Merck introduces single-use reactor to accelerate ADC manufacturing

Packaging & Supply Chain

Packaging

Gerresheimer at CPHI Frankfurt 2025

Gerresheimer

Suppliers

No data found

Drug Discovery

EffRx Pharmaceuticals signs exclusive license agreement with Diurnal for registration and commercialisation of Alkindi

Dren Bio announces a $60M Series A financing

Sanofi, Translate Bio mRNA Covid-19 vaccine candidate induced high antibody levels in preclinical studies

Eli Lilly to buy biotechnology firm Disarm Therapeutics

HitGen to acquire fragment and structure-based biotech company Vernalis

Scribe Therapeutics, Biogen collaborate to develop CRISPR-based genetic medicines

Bristol Myers Squibb to buy biopharmaceutical firm MyoKardia for $13.1bn

Covis Group to buy AMAG Pharmaceuticals for $498m

Pfizer to acquire minority stake in CStone Pharmaceuticals for $200m

Orgenesis to acquire regenerative medicine company Koligo Therapeutics

Pharmaceutical Business review is using cookies

Research & Development

Patient Enrollment

Drug Filing

Manufacturing

Packaging

No data found